Nadia P. Belichenko

Widespread changes in dendritic and axonal morphology in <i>Mecp2</i>‐mutant mouse models of rett syndrome: Evidence for disruption of neuronal networks

Pavel V. Belichenko, Elena E. Wright, Nadia P. Belichenko et al. · The Journal of Comparative Neurology · 2009 · 277 citations

Medicine, Neurobiology, Neuroscience +17

The “Down Syndrome Critical Region” Is Sufficient in the Mouse Model to Confer Behavioral, Neurophysiological, and Synaptic Phenotypes Characteristic of Down Syndrome

Nadia P. Belichenko, Pavel V. Belichenko, Alexander M. Kleschevnikov et al. · Journal of Neuroscience · 2009 · 198 citations · Full text

Life Sciences, Genetics, Neuroscience +17

A Small Molecule TrkB Ligand Reduces Motor Impairment and Neuropathology in R6/2 and BACHD Mouse Models of Huntington's Disease

Danielle A. Simmons, Nadia P. Belichenko, Tao Yang et al. · Journal of Neuroscience · 2013 · 148 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity

Eva Czirr, Nicholas A. Castello, Kira I. Mosher et al. · The Journal of Experimental Medicine · 2017 · 138 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

A Small Molecule p75NTR Ligand, LM11A-31, Reverses Cholinergic Neurite Dystrophy in Alzheimer's Disease Mouse Models with Mid- to Late-Stage Disease Progression

Danielle A. Simmons, Juliet K. Knowles, Nadia P. Belichenko et al. · PLoS ONE · 2014 · 106 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17